1395l(w)), as added by section 184 of the Medicare 
Improvements for Patients and Providers Act of 
2008 (Public Law 110–275), is amended— 
(A) by striking ‘‘PAYMENT.—The Sec-
retary’’ and inserting ‘‘PAYMENT
AND COV-
ERAGE OF ROUTINE COSTS ASSOCIATED WITH 
CLINICAL TRIALS.— 
‘‘(1) METHODS OF PAYMENT.—Subject to para-
graph (2), the Secretary’’; and 
(B) by adding at the end the following new 
paragraph: 
‘‘(2) COVERAGE
OF
ROUTINE
COSTS
ASSOCI-
ATED WITH CLINICAL TRIALS.—The Secretary shall 
not exclude from payment for items and services 
provided under a clinical trial payment for coverage 
of routine costs of care (as defined by the Secretary) 
furnished to an individual enrolled under this part 
who participates in such a trial to the extent the 
Secretary provides payment for such costs as of the 
date of enactment of this subsection.’’. 
(3) PROVIDER
OUTREACH.—The Secretary of 
Health and Human Services, acting through the Ad-
ministrator of the Centers for Medicare & Medicaid 
Services, shall conduct an outreach campaign to pro-
viders of services and suppliers under the Medicare 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00058
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
program under title XVIII of the Social Security Act 
regarding coverage of routine costs of care furnished 
to Medicare beneficiaries participating in clinical 
trials in accordance with sections 1814(m) and 
1833(w)(2) of the Social Security Act (as added by 
paragraphs (1) and (2), respectively). 
(b) COVERAGE OF CANCER CARE PLANNING SERV-
ICES.— 
(1) IN GENERAL.—Section 1861 of the Social 
Security Act, as amended by section 4103 of the Pa-
tient Protection and Affordable Care Act (Public 
Law 111–148), is amended— 
(A) in subsection (s)(2)— 
(i) by striking ‘‘and’’ at the end of 
subparagraph (EE); 
(ii) by adding ‘‘and’’ at the end of 
subparagraph (FF); and 
(iii) by adding at the end the fol-
lowing new subparagraph: 
‘‘(GG) comprehensive cancer care planning 
services (as defined in subsection (iii));’’; and 
(B) by adding at the end the following new 
subsection: 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00059
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘Comprehensive Cancer Care Planning Services 
‘‘(iii)(1) The term ‘comprehensive cancer care plan-
ning services’ means— 
‘‘(A) with respect to an individual who is 
diagnosed with cancer, the development of a 
plan of care that— 
‘‘(i) details, to the greatest extent 
practicable, all aspects of the care to be 
provided to the individual, with respect to 
the treatment of such cancer, including 
any curative treatment and comprehensive 
symptom management (such as palliative 
care) involved; 
‘‘(ii) is furnished in written form to 
the individual in person within a period 
specified by the Secretary that is as soon 
as practicable after the date on which the 
individual is so diagnosed; 
‘‘(iii) is furnished, to the greatest ex-
tent practicable, in a form that appro-
priately takes into account cultural and 
linguistic needs of the individual in order 
to make the plan accessible to the indi-
vidual; and 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00060
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(iv) is in accordance with standards 
determined by the Secretary to be appro-
priate; 
‘‘(B) with respect to an individual for 
whom a plan of care has been developed under 
subparagraph (A), the revision of such plan of 
care as necessary to account for any substantial 
change in the condition of the individual, if 
such revision— 
‘‘(i) is in accordance with clauses (i) 
and (iii) of such subparagraph; and 
‘‘(ii) is furnished in written form to 
the individual within a period specified by 
the Secretary that is as soon as practicable 
after the date of such revision; 
‘‘(C) with respect to an individual who has 
completed the primary treatment for cancer, as 
defined by the Secretary (such as completion of 
chemotherapy or radiation treatment), the de-
velopment of a follow-up cancer care plan 
that— 
‘‘(i) describes the elements of the pri-
mary treatment, including symptom man-
agement, furnished to such individual; 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00061
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(ii) provides recommendations for 
the subsequent care of the individual with 
respect to the cancer involved; 
‘‘(iii) is furnished in written form to 
the individual in person within a period 
specified by the Secretary that is as soon 
as practicable after the completion of such 
primary treatment; 
‘‘(iv) is furnished, to the greatest ex-
tent practicable, in a form that appro-
priately takes into account cultural and 
linguistic needs of the individual in order 
to make the plan accessible to the indi-
vidual; and 
‘‘(v) is in accordance with standards 
determined by the Secretary to be appro-
priate; and 
‘‘(D) with respect to an individual for 
whom a follow-up cancer care plan has been de-
veloped under subparagraph (C), the revision of 
such plan as necessary to account for any sub-
stantial change in the condition of the indi-
vidual, if such revision— 
‘‘(i) is in accordance with clauses (i), 
(ii), and (iv) of such subparagraph; and 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00062
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(ii) is furnished in written form to 
the individual within a period specified by 
the Secretary that is as soon as practicable 
after the date of such revision. 
‘‘(2) The Secretary shall establish standards to carry 
out paragraph (1) in consultation with appropriate organi-
zations representing providers of services related to cancer 
treatment and organizations representing survivors of can-
cer. Such standards shall include standards for deter-
mining the need and frequency for revisions of the plans 
of care and follow-up plans based on changes in the condi-
tion of the individual and standards for the communica-
tion of the plan to the patient.’’. 
(2) PAYMENT.—Section 1833(a)(1) of the So-
cial Security Act (42 U.S.C. 1395l(a)(1)), as amend-
ed by section 10501(g)(3)(B) of the Patient Protec-
tion and Affordable Care Act (Public Law 111–148), 
is amended by striking ‘‘and’’ before ‘‘(Z)’’ and in-
serting before the semicolon at the end the following: 
‘‘, and (AA) with respect to comprehensive cancer 
care planning services described in any of subpara-
graphs (A) through (D) of section 1861(iii)(1), the 
amount paid shall be an amount equal to the sum 
of (i) the national average amount under the physi-
cian fee schedule established under section 1848 for 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00063
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
a new patient office consultation of the highest level 
of service in the non-facility setting, and (ii) the na-
tional average amount under such fee schedule for a 
physician 
certification 
described 
in 
section 
1814(a)(2) for home health services furnished to an 
individual by a home health agency under a home 
health plan of care’’. 
(3) EFFECTIVE DATE.—The amendments made 
by this section shall apply to services furnished on 
or after the first day of the first calendar year that 
begins after the date of the enactment of this Act. 
(c) MEDICARE COVERAGE OF COMPREHENSIVE CAN-
CER PATIENT TREATMENT EDUCATION SERVICES.— 
(1) IN GENERAL.—Section 1861 of the Social 
Security Act (42 U.S.C. 1395x), as amended by sub-
section (b)(1), is further amended— 
(A) in subsection (s)(2)— 
(i) by striking ‘‘and’’ at the end of 
subparagraph (FF); 
(ii) by adding ‘‘and’’ at the end of 
subparagraph (GG); and 
(iii) by adding at the end the fol-
lowing new subparagraph: 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00064
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(HH) comprehensive cancer patient treatment 
education 
services 
(as 
defined 
in 
subsection 
(jjj)(1));’’; and 
(B) by adding at the end the following new 
subsection: 
‘‘Comprehensive Cancer Patient Treatment Education 
Services 
‘‘(jjj)(1) The term ‘comprehensive cancer patient 
treatment education services’ means— 
‘‘(A) in the case of an individual who is diag-
nosed with cancer, the provision of a one-hour pa-
tient treatment education session delivered by a reg-
istered nurse that— 
‘‘(i) is furnished to the individual and the 
caregiver (or caregivers) of the individual in ad-
vance of the onset of treatment and to the ex-
tent practicable, is not furnished on the day of 
diagnosis or on the first day of treatment; 
‘‘(ii) educates the individual and such care-
giver (or caregivers) to the greatest extent prac-
ticable, about all aspects of the care to be fur-
nished to the individual, informs the individual 
regarding any potential symptoms, side-effects, 
or adverse events, and explains ways in which 
side effects and adverse events can be mini-
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00065
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
mized and health and well-being maximized, 
and provides guidance regarding those side ef-
fects to be reported and to which health care 
provider the side effects should be reported; 
‘‘(iii) includes the provision, in written 
form, of information about the course of treat-
ment, any responsibilities of the individual with 
respect to self-dosing, and ways in which to ad-
dress symptoms and side-effects; and 
‘‘(iv) is furnished, to the greatest extent 
practicable, in an oral, written, or electronic 
form that appropriately takes into account cul-
tural and linguistic needs of the individual in 
order to make the information comprehensible 
to the individual and such caregiver (or care-
givers); and 
‘‘(B) with respect to an individual for whom a 
course of cancer treatment or therapy is materially 
modified, a one-hour patient treatment education 
session described in subparagraph (A), including up-
dated information on the matters described in such 
subparagraph should the individual’s oncologic 
health care professional deem it appropriate and 
necessary. 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00066
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(2) In establishing standards to carry out paragraph 
(1), the Secretary shall consult with appropriate organiza-
tions representing providers of oncology patient treatment 
education services and organizations representing people 
with cancer.’’. 
(2) PAYMENT.—Section 1833(a)(1) of such Act 
(42 U.S.C. 1395l(a)(1)), as amended by subsection 
(b)(2), is further amended— 
(A) by striking ‘‘and’’ before ‘‘(AA)’’; and 
(B) by inserting before the semicolon at 
the end the following: ‘‘, and (BB) with respect 
to comprehensive cancer patient treatment edu-
cation 
service 
(as 
defined 
in 
section 
1861(jjj)(1)), 150 percent of the payment rate 
established under section 1848 for diabetes out-
patient self-management training services (as 
defined in section 1861(qq)), determined and 
applied without regard to any coinsurance’’. 
(3) COVERAGE.—Section 1862(a)(1) of such 
Act (42 U.S.C. 1395y(a)(1)), as amended by section 
4103(d)(1) of the Patient Protection and Affordable 
Care Act (Public Law 111–148), is amended— 
(A) in subparagraph (O), by striking 
‘‘and’’ at the end; 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00067
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
(B) in subparagraph (P), by striking the 
semicolon at the end and inserting ‘‘, and’’; and 
(C) by adding at the end the following new 
subparagraph: 
‘‘(Q) in the case of comprehensive cancer pa-
tient treatment education services (as defined in 
subsection (jjj)(1)) which are performed more fre-
quently than is covered under such section;’’. 
(4) NO IMPACT ON PAYMENT FOR OTHER SERV-
ICES.—Nothing in this section shall be construed to 
affect or otherwise authorize any reduction or modi-
fication, in the Medicare payment amounts otherwise 
established for chemotherapy infusion or injection 
codes with respect to the calculation and payment of 
minutes for chemotherapy teaching or related serv-
ices. 
(5) EFFECTIVE DATE.—The amendments made 
by this section shall apply to services furnished on 
or after the first day of the first calendar year that 
begins after the date of the enactment of this Act. 
SEC. 10. TARGETED CANCERS PROGRAM. 
Subpart 1 of part C of title IV of the Public Health 
Service Act (42 U.S.C. 285 et seq.), as amended by section 
14, is further amended by adding at the end the following: 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00068
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘SEC. 417H. TARGETED CANCERS PROGRAM. 
‘‘(a) ESTABLISHMENT.—The Director of the Insti-
tute shall establish a targeted cancers program under 
which the Director may enter into agreements and make 
grants to conduct and coordinate research activities, with 
respect to cancers that result in a 5-year survival rate of 
less than 50 percent, for purposes of increasing such sur-
vival rate for such cancers. Such program shall include 
each of the elements described in subsections (b) through 
(i). 
‘‘(b) STRATEGIC PLAN FOR PROGRESS.— 
‘‘(1) IN GENERAL.—Under the targeted cancers 
program, the Director of the Institute, in coordina-
tion with relevant stakeholders and other appro-
priate Federal agencies, shall develop a comprehen-
sive plan, including budget amounts, for the imple-
mentation of the research activities described in this 
subsection (a) as well as the identification of addi-
tional research activities that will be necessary to in-
crease the survival for patients diagnosed with a 
cancer described in such subsection. 
‘‘(2) REPORT.—Not later than 6 months after 
the date of the enactment of this section, the Direc-
tor of the Institute shall submit to Congress and 
make publicly available the comprehensive plan de-
scribed in paragraph (1). 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00069
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(c) DEDICATED FUNDING FOR BASIC RESEARCH.— 
Under the targeted cancers program, the Director of the 
Institute shall establish a separate funding mechanism 
that can be used to fund basic research grants for inves-
tigators with a primary interest in one of the cancers de-
scribed in subsection (a). 
‘‘(d) IMAGING RESEARCH.—Under the targeted can-
cers program, the Director of the Institute shall provide 
for research to expand and advance the potential of imag-
ing to assist in early detection, disease management, and 
drug development. 
‘‘(e) INCUBATOR GRANT PROGRAM.—Under the tar-
geted cancers program, the Director of the Institute shall 
establish a high-risk, high-reward incubator grant pro-
gram for each cancer described in subsection (a) to allow 
investigators with a primary interest in such cancer an 
opportunity to build data for future grants provided by 
the Institute or the National Institutes of Health. 
‘‘(f) GRANT REVIEW
BY SCIENTIFIC EXPERTS.— 
Under the targeted cancers program, the Director of the 
Institute shall provide for a peer-review process of applica-
tions submitted for a grant under this section. Such proc-
ess shall be conducted by grant peer-review teams that in-
clude scientific experts in the specific disease area in-
volved, as well as patient advocates. 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00070
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(g) SPECIALIZED TRAINING PROGRAMS.—Under 
the targeted cancers program, the Director of the Institute 
shall provide for advanced specialized training and edu-
cation programs for early career PhD and clinician sci-
entists that ensure sufficient time of such scientists is re-
served for research in order to attract and retain a broader 
pool of investigators for the cancers specified in subsection 
(a). 
‘‘(h) SURVEILLANCE AND SCREENING.—Under the 
targeted cancers program, the Director of the Institute 
shall, as prevention, early detection, and treatments are 
identified for cancers described in subsection (a), develop 
pilot programs for the surveillance and treatment of such 
conditions that are precursors to such cancers. 
‘‘(i) 
COOPERATIVE
RESEARCH
AGREEMENTS.— 
Under the targeted cancers program, the Director of the 
Institute may enter into cooperative research agreements 
with other Federal agencies on programs targeting cancers 
specified in subsection (a), including other Institutes at 
the National Institutes of Health, other agencies within 
the Department of Health and Human Services, the De-
partment of Defense, and the Department of Veterans Af-
fairs. 
‘‘(j) IOM REPORT.— 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00071
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(1) IN GENERAL.—The Secretary of Health 
and Human Services shall enter into an arrange-
ment with the Institute of Medicine of the National 
Academies to provide an independent assessment, 
with respect to cancers described in subsection (a), 
of funding of the National Cancer Institute, progress 
of such Institute, and the additional improvements 
that should be implemented by the Department of 
Health and Human Services, by the National Insti-
tutes of Health, and by the National Cancer Insti-
tute to make sufficient progress on research related 
to such cancers. 
‘‘(2) REPORT.—The agreement entered into 
under paragraph (1) shall provide for the Institute 
of Medicine to submit to the Secretary and the Con-
gress, not later than 1 year after the date of the en-
actment of this section, a report containing a de-
scription of the results of the study conducted under 
such paragraph and the conclusions and rec-
ommendations of the Institute of Medicine regarding 
the issues described in such paragraph.’’. 
SEC. 11. ACTIVITIES OF THE FOOD AND DRUG ADMINISTRA-
TION. 
(a) REVIEW, IMPROVEMENT, AND COORDINATION.— 
The Commissioner of Food and Drugs shall— 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00072
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
(1) conduct a review of the policies, programs, 
and activities of the Food and Drug Administration 
relating to oncology products; and 
(2) based on the results of such review, improve 
and coordinate such policies, programs, and activi-
ties, including by— 
(A) integrating policies, programs, activi-
ties, and, if appropriate, organizational units of 
the Administration to facilitate the concurrent 
development of oncology products; 
(B) considering alternatives or surrogates 
to traditional clinical trial endpoints (for exam-
ple, other than survival) that are acceptable for 
regulatory approval as evidence of clinical ben-
efit to patients; and 
(C) modernizing the Office of Oncology 
Drug Products by examining and addressing in-
ternal barriers that exist within the Office’s or-
ganizational structure. 
(b) DEFINITIONS.—In this section: 
(1) The term ‘‘biological product’’ has the 
meaning given to that term in section 351 of the 
Public Health Service Act (42 U.S.C. 262). 
(2) The terms ‘‘device’’ and ‘‘drug’’ have the 
meanings given to those terms in section 201 of the 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00073
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
321). 
(3) The term ‘‘oncology product’’ means— 
(A) any biological product, drug, or device 
for cancer diagnosis, prevention, or treatment; 
or 
(B) any other product that is regulated by 
the Food and Drug Administration and is de-
termined by the Commissioner of Food and 
Drugs to be relevant to cancer diagnosis, pre-
vention, or treatment. 
SEC. 12. CDC CANCER CONTROL PROGRAMS. 
Part B of title III of the Public Health Service Act 
(42 U.S.C. 243 et seq.), as amended by section 6, is fur-
ther amended by inserting after section 317U the fol-
lowing: 
‘‘SEC. 317V. CANCER CONTROL PROGRAMS. 
‘‘(a) IN GENERAL.—The Secretary, acting through 
the Director of the Centers for Disease Control and Pre-
vention, shall expand and intensify the cancer control pro-
grams of the Centers, including programs for conducting 
surveillance activities or supporting State comprehensive 
cancer control plans. 
‘‘(b) CERTAIN ACTIVITIES.—In carrying out sub-
section (a), the Secretary shall— 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00074
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(1) in collaboration with the Director of the 
National Cancer Institute, provide guidance to 
States on projects and interventions that may be in-
corporated into State comprehensive cancer control 
programs to improve the long-term health status of 
childhood cancer survivors, including childhood can-
cer survivors in minority and other medically under-
served populations; 
‘‘(2) encourage States to incorporate strategies 
for improving systems of care for childhood cancer 
survivors and their families into State comprehensive 
cancer plans; and 
‘‘(3) collaborate with the Director of the Na-
tional Cancer Institute to improve existing surveil-
lance systems or develop appropriate new systems 
for tracking cancer survivors and assessing their 
health status and risk for other chronic and dis-
abling conditions. 
‘‘(c) CHILDHOOD CANCER SURVIVORSHIP.— 
‘‘(1) FOCUS ON CHILDHOOD CANCER SURVIVOR-
SHIP.—In conducting or supporting national, State, 
and local comprehensive cancer control programs 
through the Centers for Disease Control and Preven-
tion, the Secretary shall enhance such programs— 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00075
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(A) to include a focus on childhood cancer 
survivorship, including survivorship in minority 
and other medically underserved populations; 
and 
‘‘(B) to include childhood cancer survivor-
ship initiatives for improving— 
‘‘(i) the monitoring of survivors of all 
forms of cancer; and 
‘‘(ii) follow-up treatment for childhood 
cancer survivors. 
‘‘(2) RELIANCE ON GUIDELINES.—In carrying 
out this subsection, the Secretary shall rely, where 
appropriate, on existing guidelines for care of child-
hood cancer survivors.’’. 
SEC. 13. NIH CANCER SURVIVORSHIP PROGRAMS. 
(a) TECHNICAL AMENDMENT.— 
(1) 
IN
GENERAL.—Section 
of 
the 
Hematological Cancer Research Investment and 
Education Act of 2002 (Public Law 107–172; 116 
Stat. 541) is amended by striking ‘‘section 419C’’ 
and inserting ‘‘section 417C’’. 
(2) EFFECTIVE DATE.—The amendment made 
by paragraph (1) shall take effect as if included in 
section 3 of the Hematological Cancer Research In-
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00076
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
vestment and Education Act of 2002 (Public Law 
107–172; 116 Stat. 541). 
(b) CANCER SURVIVORSHIP PROGRAMS.—Subpart 1 
of part C of title IV of the Public Health Service Act (42 
U.S.C. 285 et seq.), is amended by adding at the end the 
following: 
‘‘SEC. 417G. EXPANSION OF CANCER SURVIVORSHIP ACTIVI-
TIES. 
‘‘(a) EXPANSION OF ACTIVITIES.—The Director of 
the Institute shall coordinate the activities of the National 
Institutes of Health with respect to cancer survivorship, 
including childhood cancer survivorship. 
‘‘(b) PRIORITY AREAS.—In carrying out subsection 
(a), the Director of the Institute shall give priority to the 
following: 
‘‘(1) Comprehensive assessment of the preva-
lence and etiology of late effects of cancer and its 
treatment, including physical, neu-rocognitive, and 
psychosocial late effects. Such assessment shall in-
clude— 
‘‘(A) development of a system for patient 
tracking and analysis; 
‘‘(B) establishment of a system of tissue 
collection, banking, and analysis for childhood 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00077
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
cancers, using guidelines from the Office of 
Biorepositories and Biospecimen Research; and 
‘‘(C) coordination of, and resources for, as-
sessment and data collection. 
‘‘(2) Identification of risk and protective factors 
related to the development of late effects of cancer. 
‘‘(3) 
Identification 
of 
predictors 
of 
neu-
rocognitive and psychosocial outcomes, including 
quality of life, in cancer survivors and identification 
of qualify of life and other outcomes in family mem-
bers. 
‘‘(4) Development and implementation of inter-
vention studies for patients and families, including 
studies focusing on— 
‘‘(A) preventive interventions during treat-
ment; 
‘‘(B) interventions to lessen the impact of 
late effects; 
‘‘(C) rehabilitative or remediative interven-
tions; 
‘‘(D) interventions to promote health be-
haviors in long-term survivors; and 
‘‘(E) interventions to improve health care 
utilization and access to linguistically and cul-
turally competent long-term follow-up care for 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00078
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
childhood cancer survivors in minority and 
other medically underserved populations. 
‘‘(c) GRANTS
FOR
RESEARCH
ON
CAUSES
OF 
HEALTH DISPARITIES IN CHILDHOOD CANCER SURVI-
VORSHIP.— 
‘‘(1) GRANTS.—The Director of NIH, acting 
through the Director of the Institute, shall make 
grants to entities to conduct research relating to— 
‘‘(A) childhood cancer survivors within mi-
nority populations; and 
‘‘(B) health disparities in cancer survivor-
ship outcomes within minority or other medi-
cally underserved populations. 
‘‘(2) BALANCED APPROACH.—In making grants 
for research under paragraph (1)(A) on childhood 
cancer survivors within minority populations, the Di-
rector of NIH shall ensure that such research ad-
dresses both the physical and the psychosocial needs 
of such survivors. 
‘‘(3) HEALTH DISPARITIES.—In making grants 
for research under paragraph (1)(B) on health dis-
parities in cancer survivorship outcomes within mi-
nority populations, the Director of NIH shall ensure 
that such research examines each of the following: 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00079
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(A) Key adverse events after childhood 
cancer. 
‘‘(B) Assessment of health and quality of 
life in childhood cancer survivors. 
‘‘(C) Barriers to follow-up care to child-
hood cancer survivors. 
‘‘(d) RESEARCH TO EVALUATE FOLLOW-UP CARE 
FOR CHILDHOOD CANCER SURVIVORS.—The Director of 
NIH shall conduct or support research to evaluate systems 
of follow-up care for childhood cancer survivors, with spe-
cial emphasis given to— 
‘‘(1) transitions in care for childhood cancer 
survivors; 
‘‘(2) those professionals who should be part of 
care teams for childhood cancer survivors; 
‘‘(3) training of professionals to provide linguis-
tically and culturally competent follow-up care to 
childhood cancer survivors; and 
‘‘(4) different models of follow-up care. 
‘‘SEC. 417G–1. IMPROVING THE QUALITY OF FOLLOW-UP 
CARE FOR SURVIVORS OF CHILDHOOD CAN-
CERS AND THEIR FAMILIES. 
‘‘(a) IN GENERAL.—The Secretary, in consultation 
with the Director of NIH, shall make grants to eligible 
entities to establish or improve training programs for 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00080
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
health care professionals (including physicians, nurses, 
physician assistants, and mental health professionals)— 
‘‘(1) to improve the quality of immediate and 
long-term follow-up care for survivors of childhood 
cancers and their families; and 
‘‘(2) to ensure that such care is linguistically 
and culturally competent. 
‘‘(b) ELIGIBLE ENTITIES.—In this section, the term 
‘eligible entity’ means— 
‘‘(1) a medical school; 
‘‘(2) a children’s hospital; 
‘‘(3) a cancer center; 
‘‘(4) a hospital with one or more residency pro-
grams that serve a significant number of childhood 
cancer patients; 
‘‘(5) a graduate training program for health 
professionals described in subsection (a) who will 
treat survivors of childhood cancers; or 
‘‘(6) any other entity with significant experience 
and expertise in treating survivors of childhood can-
cers. 
‘‘(c) DURATION.—Each grant under this section shall 
be for a period of 2 years. 
‘‘(d) AUTHORIZATION
OF
APPROPRIATIONS.—To 
carry out this section, there is authorized to be appro-
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00081
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
priated $5,000,000 for each of fiscal years 2012 through 
2016. 
‘‘SEC. 417G–2. STUDY OF PILOT PROGRAMS TO EXPLORE 
MODEL SYSTEMS OF CARE. 
‘‘(a) IN GENERAL.—The Director of NIH, in con-
sultation with the Administrator of the Health Resources 
and Services Administration, shall make grants to eligible 
entities to establish pilot programs to develop, study, or 
evaluate model systems for monitoring and caring for 
childhood cancer survivors. 
‘‘(b) ELIGIBLE ENTITIES.—In this section, the term 
‘eligible entity’ means— 
‘‘(1) a medical school; 
‘‘(2) a children’s hospital; 
‘‘(3) a cancer center; or 
‘‘(4) any other entity with significant experience 
and expertise in treating survivors of childhood can-
cers. 
‘‘(c) USE OF FUNDS.—The Director of NIH may 
make a grant under this section to an eligible entity only 
if the entity agrees— 
‘‘(1) to use the grant to establish a pilot pro-
gram to develop, study, or evaluate one or more 
model systems for monitoring and caring for cancer 
survivors; and 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00082
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(2) in developing, studying, and evaluating 
such systems, to give special emphasis to the fol-
lowing: 
‘‘(A) Design of protocols for follow-up 
care, monitoring, and other survivorship pro-
grams (including peer support and mentoring 
programs). 
‘‘(B) Dissemination of information to 
health care providers about how to provide lin-
guistically and culturally competent follow-up 
care and monitoring to cancer survivors and 
their families. 
‘‘(C) Dissemination of other information, 
as appropriate, to health care providers and to 
cancer survivors and their families. 
‘‘(D) Development of support programs to 
improve the quality of life of cancer survivors. 
‘‘(E) Design of systems for the effective 
transfer of treatment information from cancer 
care providers to other health care providers 
(including family practice physicians and inter-
nists) and to cancer survivors and their fami-
lies, where appropriate. 
‘‘(F) Development of various models for 
providing multidisciplinary care. 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00083
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(d) AUTHORIZATION
OF
APPROPRIATIONS.—To 
carry out this section, there is authorized to be appro-
priated $10,000,000 for each of fiscal years 2012 through 
2016.’’. 
(c) COMPLETE RECOVERY CARE.— 
(1) DEFINITION.—In this subsection, the term 
‘‘complete recovery care’’ means care intended to ad-
dress the secondary effects of cancer and its treat-
ment, including late, psychosocial, neurocognitive, 
psychiatric, psychological, physical, and other effects 
associated with cancer and cancer survivorship be-
yond the impairment of bodily function directly 
caused by the disease, as described in the report by 
the Institute of Medicine of the National Academies 
entitled ‘‘Cancer Care for the Whole Patient’’. 
(2) EXPANSION OF ACTIVITIES.—The Secretary 
of Health and Human Services (referred to in this 
subsection as the ‘‘Secretary’’) shall— 
(A) coordinate the activities of Federal 
agencies, including the National Institutes of 
Health, the National Cancer Institute, the Na-
tional Institute of Mental Health, the Centers 
for Medicare and Medicaid Services, the Vet-
erans Health Administration, the Centers for 
Disease Control and Prevention, the Food and 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00084
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
Drug 
Administration, 
the 
Agency 
for 
Healthcare Research and Quality, the Office for 
Human Research Protections, and the Health 
Resources and Services Administration to im-
prove the provision of complete recovery care in 
the treatment of cancer; and 
(B) solicit input from professional and pa-
tient organizations, payors, and other relevant 
institutions and organizations regarding the 
status of provision of complete recovery care in 
the treatment of cancer. 
(3) IMPROVING
THE
COMPLETE
RECOVERY 
CARE WORKFORCE.— 
(A) CHRONIC
DISEASE
WORKFORCE
DE-
VELOPMENT
COLLABORATIVE.—The Secretary 
shall, not later than 1 year after the date of en-
actment of this Act, convene a Workforce De-
velopment Collaborative on Psychosocial Care 
During Chronic Medical Illness (referred to in 
this paragraph as the ‘‘Collaborative’’). The 
Collaborative shall be a cross-specialty, multi-
disciplinary group composed of educators, con-
sumer and family advocates, and providers of 
psychosocial and biomedical health services. 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00085
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
(B) GOALS
AND
REPORT.—The Collabo-
rative shall submit to the Secretary a report es-
tablishing a plan to meet the following objec-
tives for psychosocial care workforce develop-
ment: 
(i) Identifying, refining, and broadly 
disseminating to healthcare educators in-
formation about workforce competencies, 
models, and preservices curricula relevant 
to providing psychosocial services to per-
sons with chronic medical illnesses and 
their families. 
(ii) Adapting curricula for continuing 
education of the existing workforce using 
efficient 
workplace-based 
learning 
ap-
proaches. 
(iii) Developing the skills of faculty 
and other trainers in teaching psychosocial 
health care using evidence-based teaching 
strategies. 
(iv) Strengthening the emphasis on 
psychosocial healthcare in educational ac-
creditation standards and professional li-
censing and certification exams by recom-
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00086
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
mending revisions to the relevant oversight 
organizations. 
SEC. 14. CLINICS FOR COMPREHENSIVE LONG-TERM FOL-
LOW-UP SERVICES FOR CHILDHOOD CANCER 
SURVIVORS. 
Part B of title III of the Public Health Service Act 
(42 U.S.C. 243 et seq.), as amended by sections 6 and 
13, is further amended by inserting after section 317V the 
following: 
‘‘SEC. 317W. CLINICS FOR COMPREHENSIVE LONG-TERM 
FOLLOW-UP SERVICES FOR CHILDHOOD CAN-
CER SURVIVORS. 
‘‘(a) IN GENERAL.—The Secretary shall make grants 
to eligible entities to pay all or a portion of the costs in-
curred during the first 4 years of establishing and oper-
ating a clinic for comprehensive long-term follow-up serv-
ices for childhood cancer survivors. 
‘‘(b) ELIGIBLE ENTITIES.—In this section, the term 
‘eligible entity’ means— 
‘‘(1) a school of medicine; 
‘‘(2) a children’s hospital; 
‘‘(3) a cancer center; or 
‘‘(4) any other entity with significant experience 
and expertise in treating survivors of childhood can-
cers. 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00087
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(c) PRIORITY.—In making grants under this sec-
tion, the Secretary shall give priority to any eligible entity 
that demonstrates an expertise in improving access to care 
for minority and other medically underserved populations. 
‘‘(d) USE OF FUNDS.—The Secretary may make a 
grant under this section to an eligible entity only if the 
entity agrees to use the grant to pay costs incurred during 
the first 4 years of establishing and operating a clinic for 
comprehensive long-term follow-up services for childhood 
cancer survivors. Such costs may include the costs of— 
‘‘(1) purchasing or leasing facilities; 
‘‘(2) providing medical and psychosocial follow- 
up services, including coordination with the patient’s 
primary care provider and oncologist in order to en-
sure that the unique medical needs of survivors are 
addressed; 
‘‘(3) conducting research to improve care for 
childhood cancer survivors; 
‘‘(4) providing linguistically and culturally com-
petent information to childhood cancer survivors and 
their families; and 
‘‘(5) improving access by minority or other 
medically underserved populations to the best prac-
tices and care for childhood cancer survivors. 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00088
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(e) AUTHORIZATION
OF
APPROPRIATIONS.—To 
carry out this section, there is authorized to be appro-
priated $15,000,000 for each of fiscal years 2012 through 
2016.’’. 
SEC. 15. GRANTS TO IMPROVE ACCESS TO CARE FOR 
CHILDHOOD CANCER SURVIVORS. 
Part B of title III of the Public Health Service Act 
(42 U.S.C. 243 et seq.), as amended by sections 6, 13, 
and 15, is further amended by inserting after section 
317W the following: 
‘‘SEC. 317X. GRANTS TO IMPROVE ACCESS TO CARE FOR 
CHILDHOOD CANCER SURVIVORS. 
‘‘(a) GRANTS.—The Secretary shall make grants to 
recognized childhood cancer professional and advocacy or-
ganizations to improve physical and psychosocial care for 
childhood cancer survivors, especially childhood cancer 
survivors in minority or other medically underserved popu-
lations. 
‘‘(b) USE OF FUNDS.—The Secretary may make a 
grant under this section to an organization only if the or-
ganization agrees to use the grant to improve physical and 
psychosocial care for childhood cancer survivors, especially 
childhood cancer survivors in minority or other medically 
underserved populations. Such care may include— 
‘‘(1) patient navigator programs; 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00089
Fmt 6652
Sfmt 6201
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS
‘‘(2) peer support programs; 
‘‘(3) education and outreach for survivors and 
their families, including developing bilingual mate-
rials; 
‘‘(4) follow-up care for uninsured and under-
insured survivors— 
‘‘(A) to identify, prevent, or control side ef-
fects associated with cancer and its treatment; 
and 
‘‘(B) to screen for cancer recurrence; and 
‘‘(5) assistance with transportation necessary to 
receive medical care for survivors and their families 
who lack adequate transportation resources. 
‘‘(c) AUTHORIZATION
OF
APPROPRIATIONS.—To 
carry out this section, there is authorized to be appro-
priated $10,000,000 for each of fiscal years 2012 through 
2016.’’. 
Æ 
VerDate Mar 15 2010 
02:37 Oct 05, 2010
Jkt 099200
PO 00000
Frm 00090
Fmt 6652
Sfmt 6301
E:\BILLS\H6224.IH
H6224
jbell on DSKDVH8Z91PROD with BILLS